Snowwater Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Buy
1,116
+78
+8% +$79.1K 0.97% 28
2025
Q4
$1.12M Buy
+1,038
New +$993K 1.03% 27

Other funds holding LLY

Snowwater Investment Partners's LLY Position: Q1 2026 in Review

Snowwater Investment Partners increased its Eli Lilly (LLY) stake by 7.5% in Q1 2026, buying an estimated $79.1K and bringing the position to 1,116 shares worth $1.03M. The position accounts for 0.97% of the portfolio, ranked #28.

Snowwater Investment Partners first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.12M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Snowwater Investment Partners held 1,116 shares of Eli Lilly worth $1.03M as of Q1 2026.
  • Snowwater Investment Partners bought 78 Eli Lilly shares in Q1 2026, an estimated $79.1K.
  • Eli Lilly made up 0.97% of Snowwater Investment Partners's portfolio in Q1 2026, its #28 holding.
  • Snowwater Investment Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Snowwater Investment Partners's Eli Lilly position peaked at $1.12M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Snowwater Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.